To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Celtic fund reaches $100m on way to $700m
Celtic Therapeutics, based in the Virgin Islands, will seek to exploit a ‘crisis’ in the pharmaceutical industry by buying early-to mid-stage drug development programmes. The fund is the successor to Celtic Pharmaceuticals, which reached $400m in commitments and mezzanine funding for investment in drug development programmes.
